SCHEDULE: Juniper Investment Boosts Orthofix Stake to 8.2%

Juniper Investment Company and its affiliates have increased their beneficial ownership in Orthofix Medical Inc. to 8.2% through recent open market purchases.

Summary

• Juniper Investment Company, LLC and its affiliated funds (Juniper Targeted Opportunity Fund, L.P., Juniper Targeted Opportunities, L.P., and Juniper Multi-Strategy Fund, L.P.) collectively beneficially own 3,243,284 shares of Orthofix Medical Inc. common stock.
• This aggregate ownership represents approximately 8.2% of Orthofix Medical Inc.'s outstanding shares, based on 39,494,265 shares reported as outstanding as of July 31, 2025.
• Between September 26, 2025, and October 17, 2025, Juniper Targeted Opportunity Fund, L.P. purchased 109,746 shares for approximately $1,596,729 in the open market.
• Between October 10, 2025, and October 17, 2025, Juniper Targeted Opportunities, L.P. purchased 288,432 shares for approximately $4,154,056 in the open market.
• The total recent purchases by Juniper entities amount to 398,178 shares for an aggregate price of approximately $5,750,785.
• Alexis P. Michas and John A. Bartholdson, as managing members of the Juniper entities, are deemed to share beneficial ownership of these shares.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as a significant institutional investor has increased its stake in the company, indicating confidence in its value or future performance. This is a factual disclosure of ownership, not a performance report, so the positive sentiment is derived from the action of the investor.

Positives

• A significant institutional investor, Juniper Investment Company and its affiliates, has increased its stake in Orthofix Medical Inc., signaling confidence in the company's prospects.
• The recent open market purchases demonstrate active investment and a growing commitment to the company by a sophisticated investor group.

Future Outlook

NA

Industry Context

This filing reflects an increased stake by an institutional investor in Orthofix Medical Inc., a company operating in the medical device sector. Such an increase in ownership by a significant investor can be interpreted as a positive signal regarding the company's valuation or future prospects within its industry.

Stakeholder Impact

• Shareholders: The increased institutional ownership by Juniper Investment Company and its affiliates may be viewed positively, potentially signaling a vote of confidence in Orthofix Medical Inc.'s future and possibly influencing market perception and share price.

Key Dates

Recommendation

The filing indicates a significant institutional investor, Juniper Investment Company, has increased its stake in Orthofix Medical Inc. to 8.2% through open market purchases. This action suggests a positive outlook from a sophisticated investor, which could be a favorable signal for existing shareholders. However, as this is purely an ownership disclosure and not a financial performance report or strategic announcement by the company itself, a 'hold' recommendation is appropriate. It acknowledges the positive signal from increased institutional confidence without implying a 'buy' based on operational or financial results not detailed in this filing.

Keywords

Orthofix Medical Inc., Juniper Investment Company, Beneficial Ownership, Schedule 13D, Medical Devices, Institutional Investor, Common Stock, Share Acquisition